Clarivate Plc (NYSE:CLVT) Stock Position Decreased by Advantage Alpha Capital Partners LP

Advantage Alpha Capital Partners LP decreased its stake in shares of Clarivate Plc (NYSE:CLVT - Free Report) by 30.1% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 759,171 shares of the company's stock after selling 326,993 shares during the period. Clarivate comprises about 1.2% of Advantage Alpha Capital Partners LP's investment portfolio, making the stock its 29th biggest holding. Advantage Alpha Capital Partners LP owned about 0.11% of Clarivate worth $5,390,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of the company. FMR LLC lifted its holdings in Clarivate by 8.6% during the 3rd quarter. FMR LLC now owns 5,088,942 shares of the company's stock worth $36,131,000 after buying an additional 401,920 shares during the last quarter. D.A. Davidson & CO. acquired a new stake in shares of Clarivate during the 3rd quarter valued at approximately $159,000. Pitcairn Co. bought a new position in Clarivate during the third quarter worth $100,000. Cerity Partners LLC boosted its holdings in Clarivate by 82.5% in the third quarter. Cerity Partners LLC now owns 202,204 shares of the company's stock worth $1,436,000 after purchasing an additional 91,384 shares during the period. Finally, Charles Schwab Investment Management Inc. increased its stake in Clarivate by 0.8% during the third quarter. Charles Schwab Investment Management Inc. now owns 4,604,449 shares of the company's stock valued at $32,692,000 after purchasing an additional 38,355 shares during the last quarter. 85.72% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, Director Saurabh Saha sold 17,646 shares of Clarivate stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $6.75, for a total transaction of $119,110.50. Following the transaction, the director now directly owns 23,741 shares of the company's stock, valued at $160,251.75. The trade was a 42.64 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Michael J. Angelakis purchased 1,500,000 shares of the business's stock in a transaction on Wednesday, November 20th. The stock was acquired at an average cost of $5.11 per share, with a total value of $7,665,000.00. Following the completion of the acquisition, the director now directly owns 1,500,000 shares in the company, valued at $7,665,000. The trade was a ∞ increase in their position. The disclosure for this purchase can be found here. Insiders sold 197,646 shares of company stock valued at $1,379,111 over the last 90 days. 23.14% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

CLVT has been the topic of a number of recent research reports. Barclays reduced their price target on shares of Clarivate from $5.00 to $4.00 and set an "underweight" rating on the stock in a research report on Thursday, November 7th. William Blair downgraded Clarivate from an "outperform" rating to a "market perform" rating in a research note on Wednesday, November 6th. Finally, Royal Bank of Canada dropped their price target on Clarivate from $7.00 to $6.00 and set a "sector perform" rating on the stock in a research report on Thursday, November 7th. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Hold" and an average price target of $7.25.

Clarivate Stock Performance

Shares of CLVT traded down $0.16 during mid-day trading on Tuesday, reaching $5.58. 6,814,045 shares of the company's stock traded hands, compared to its average volume of 4,541,682. The company has a debt-to-equity ratio of 0.84, a quick ratio of 0.88 and a current ratio of 0.88. The business's 50-day moving average price is $6.17 and its 200-day moving average price is $6.11. The stock has a market capitalization of $3.96 billion, a P/E ratio of -2.80 and a beta of 1.18. Clarivate Plc has a 12 month low of $4.25 and a 12 month high of $9.60.

Clarivate (NYSE:CLVT - Get Free Report) last announced its earnings results on Wednesday, November 6th. The company reported $0.19 earnings per share for the quarter, meeting the consensus estimate of $0.19. Clarivate had a positive return on equity of 9.69% and a negative net margin of 50.00%. The firm had revenue of $622.20 million for the quarter, compared to the consensus estimate of $640.81 million. During the same quarter in the previous year, the business earned $0.18 EPS. The firm's revenue for the quarter was down 3.9% on a year-over-year basis. Equities analysts predict that Clarivate Plc will post 0.63 earnings per share for the current year.

Clarivate Profile

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.